Factors that predict the successful eradication when treating H. pylori infection: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
(6 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{CMG}}; {{AE}} {{MKK}}, {{SSW}}
{{CMG}}; {{AE}} {{MKK}}, {{SSW}}
{{Peptic ulcer}}
==2017 ACG Guidelines for factors that predict the successful eradication when treating H. pylori infection==
==2017 ACG Guidelines for factors that predict the successful eradication when treating H. pylori infection==
{| class="wikitable"
|-
| colspan="1" style="text-align:center; background:LightGreen" |Strong recommendation
|-
| bgcolor="LightGreen" |1.Bismuth quadruple therapy consisting of a PPI, bismuth, tetracycline, and a nitroimidazole for 10–14 days is a recommended fi rst-line treatment option.
Bismuth quadruple therapy is particularly attractive in patients with any previous macrolide exposure or who are allergic to penicillin
|-
| bgcolor="LightGreen" |2.Concomitant therapy consisting of a PPI, clarithromycin, amoxicillin and a nitroimidazole for 10–14 days is a recommended fi rst-line treatment option
|-
|}


{| class="wikitable"  
{| class="wikitable"  
Line 22: Line 9:
| colspan="1" style="text-align:center; background:LemonChiffon" |Conditional recommendation
| colspan="1" style="text-align:center; background:LemonChiffon" |Conditional recommendation
|-
|-
| bgcolor="LemonChiffon" |'''1.'''Patients should be asked about any previous antibiotic exposure(s) and this information should be taken into consideration when choosing an H. pylori
| bgcolor="LemonChiffon" |1.The main determinants of successful [[H. pylori]] eradication are the choice of the regimen, the patient’s adherence to a multi-drug regimen with frequent
treatment regimen '''.'''
side-effects and the sensitivity of the [[H. pylori]] strain to the combination of [[antibiotics]] administered.<ref name="urlwww.nature.com2">{{cite web |url=https://www.nature.com/ajg/journal/v112/n2/pdf/ajg2016563a.pdf |title=www.nature.com |format= |work= |accessdate=}}</ref>
|-
|-
| bgcolor="LemonChiffon" |2.Clarithromycin triple therapy consisting of a PPI, clarithromycin, and amoxicillin or metronidazole for 14 days remains a recommended treatment in regions
|}
where H. pylori clarithromycin resistance is known to be <15% and in patients with no previous history of macrolide exposure for any reason.
|-
| bgcolor="LemonChiffon" |3.Sequential therapy consisting of a PPI and amoxicillin for 5–7 days followed by a PPI, clarithromycin, and a nitroimidazole for 5–7 days is a suggested first line
 
treatment option.
 
|-
|-
| bgcolor="LemonChiffon" |4.Hybrid therapy consisting of a PPI and amoxicillin for 7 days followed by a PPI, amoxicillin, clarithromycin and a nitroimidazole for 7 days is a suggested


first-line treatment option.
==References==
|-
{{reflist|2}}
| bgcolor="LemonChiffon" |5.Levofloxacin triple therapy consisting of a PPI, levofloxacin, and amoxicillin for 10–14 days is a suggested first-line treatment option.
|-
| bgcolor="LemonChiffon" |6.Fluoroquinolone sequential therapy consisting of a PPI and amoxicillin for 5–7 days followed by a PPI, fluoroquinolone, and nitroimidazole for 5–7 days is a
suggested first-line treatment option.
|}

Latest revision as of 20:38, 12 December 2017


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2], Sargun Singh Walia M.B.B.S.[3]

Peptic ulcer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Peptic Ulcer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Upper GI Endoscopy

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Endoscopic management
Surgical management

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

2017 ACG Guidelines for Peptic Ulcer Disease

Guidelines for the Indications to Test for, and to Treat, H. pylori Infection

Guidelines for First line Treatment Strategies of Peptic Ulcer Disease for Providers in North America

Guidlines for factors that predict the successful eradication when treating H. pylori infection

Guidelines to document H. pylori antimicrobial resistance in the North America

Guidelines for evaluation and testing of H. pylori antibiotic resistance

Guidelines for when to test for treatment success after H. pylori eradication therapy

Guidelines for penicillin allergy in patients with H. pylori infection

Guidelines for the salvage therapy

Factors that predict the successful eradication when treating H. pylori infection On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Factors that predict the successful eradication when treating H. pylori infection

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Factors that predict the successful eradication when treating H. pylori infection

CDC on Factors that predict the successful eradication when treating H. pylori infection

Factors that predict the successful eradication when treating H. pylori infection in the news

Blogs on Factors that predict the successful eradication when treating H. pylori infection

to Hospitals Treating Peptic ulcer

Risk calculators and risk factors for Factors that predict the successful eradication when treating H. pylori infection

2017 ACG Guidelines for factors that predict the successful eradication when treating H. pylori infection

Conditional recommendation
1.The main determinants of successful H. pylori eradication are the choice of the regimen, the patient’s adherence to a multi-drug regimen with frequent

side-effects and the sensitivity of the H. pylori strain to the combination of antibiotics administered.[1]

References

  1. ↑ "www.nature.com" (PDF).
Retrieved from "https://www.wikidoc.org/index.php?title=Factors_that_predict_the_successful_eradication_when_treating_H._pylori_infection&oldid=1405281"